- Home
- TARA vs ZOM Comparison
TARA vs ZOM Comparison
Compare TARA & ZOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- ZOM
- Stock Information
- Founded
- TARA N/A
- ZOM 2015
- Country
- TARA United States
- ZOM United States
- Employees
- TARA N/A
- ZOM N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- ZOM Biotechnology: Pharmaceutical Preparations
- Sector
- TARA Health Care
- ZOM Health Care
- Exchange
- TARA Nasdaq
- ZOM Nasdaq
- Market Cap
- TARA 158.2M
- ZOM 128.4M
- IPO Year
- TARA N/A
- ZOM N/A
- Fundamental
- Price
- TARA $3.72
- ZOM $0.12
- Analyst Decision
- TARA Strong Buy
- ZOM
- Analyst Count
- TARA 3
- ZOM 0
- Target Price
- TARA $22.67
- ZOM N/A
- AVG Volume (30 Days)
- TARA 270.4K
- ZOM 3.4M
- Earning Date
- TARA 03-12-2025
- ZOM 03-31-2025
- Dividend Yield
- TARA N/A
- ZOM N/A
- EPS Growth
- TARA N/A
- ZOM N/A
- EPS
- TARA N/A
- ZOM N/A
- Revenue
- TARA N/A
- ZOM $26,727,000.00
- Revenue This Year
- TARA N/A
- ZOM $10.28
- Revenue Next Year
- TARA N/A
- ZOM $28.00
- P/E Ratio
- TARA N/A
- ZOM N/A
- Revenue Growth
- TARA N/A
- ZOM 11.33
- 52 Week Low
- TARA $1.60
- ZOM $0.12
- 52 Week High
- TARA $10.48
- ZOM $0.20
- Technical
- Relative Strength Index (RSI)
- TARA 33.05
- ZOM 41.88
- Support Level
- TARA $3.91
- ZOM $0.12
- Resistance Level
- TARA $4.05
- ZOM $0.12
- Average True Range (ATR)
- TARA 0.29
- ZOM 0.00
- MACD
- TARA -0.07
- ZOM 0.00
- Stochastic Oscillator
- TARA 0.00
- ZOM 3.03
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.